M1 and M2 markers should be interpreted as patterns rather than a binary label. A macrophage can display features associated with inflammatory activity and resolution or repair, depending on the signals present. This continuum matters because assigning a single marker to one fixed state can oversimplify responses during infection, inflammation, or tissue healing.
Stimulus selection strongly influences the profile detected. Lipopolysaccharide and interferon-γ are associated with M1-linked inflammatory mediators, whereas interleukin-4 and interleukin-13 are associated with M2-linked features. These inputs help researchers examine how particular immune signals influence macrophage behavior and which marker set best reflects the response under study.
Individual markers provide limited information when considered alone. A panel that combines inducible nitric oxide synthase, tumor necrosis factor, and CD86 with CD206, arginase-1, and interleukin-10 gives a broader view of activation. Comparing the pattern helps distinguish mixed or intermediate responses from profiles dominated by one group of associated features.
A useful assessment begins by identifying the signals and biological context under investigation, then selecting markers that represent both inflammatory and resolution- or repair-associated features. Researchers can compare the resulting marker pattern rather than relying on one measurement. This approach keeps the analysis aligned with the research question and with the continuum of macrophage states.
These marker profiles are useful across infection, inflammation, and healing studies because they connect macrophage responses with different biological contexts. M1-associated measurements can help evaluate inflammatory activity linked with microbial or cytokine stimulation, while M2-associated measurements can help examine signals related to resolution and tissue repair. The same panel can support comparisons across conditions.
Interpretation depends on the experimental context and the combination of signals present. A profile containing CD86 or tumor necrosis factor should not automatically be treated as exclusively M1, just as CD206 or interleukin-10 should not be read as proof of a purely M2 state. Reporting several markers preserves the continuum model and reduces overinterpretation.